Entrectinib (Rozlytrek™) is a kinase inhibitor used in the treatment of non small cell lung cancer and other solid tumors with certain neurotrophic receptor kinase (NTRK) genes.
What's New
FAQ about this common recommendation.
How do providers decide which people will benefit from chemotherapy with stage II colon cancer?
Darolutamide (Nubeqa®) is an androgen receptor inhibitor used in the treatment of patients with non-metastatic, castration-resistant prostate cancer.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
View all Blogs
Cancer Awareness
Summer Sun Safety Month
It’s summertime - that means fun, sun and vacations! Just because you are going through cancer treatment doesn’t mean you can’t take a vacation. Watch the Cancer Goes to the Beach webinar to get tips and resources to plan a safe and stress free getaway. July is also UV Safety Month – learn all you need to know to stay sun safe this summer.
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.